Hopes that angiogenesis inhibition could improve outcomes when used adjuvantly in colorectal cancer received a setback at the end of April, with the announcement that the NSABP C-08 trial had failed to meet its primary [more]
Selected repor ts edited by Janet Fricker Download full article
Results froma retrospective reviewof data from patients who under went resection for colorectal liver metastases indicate that partial hepatectomy for four or more hepatic colorectal cancer metastases is no longer contraindicated and is associated with [more]
Selected reports edited by Hannah Brown Download full article
After years of relying on 5FU, colorectal cancer clinicians now have a wealth of targeted therapies and combination protocols to choose from. The question is, what to use in which patients and when? Download full [more]
It takes a surgeon to stop a surgeon, says John Northover, consultant surgeon at London’s world-renowned colorectal hospital. And between his heavy clinical and teaching commitments, he concentrates on helping minimise patient interventions, through promoting [more]
A new predictive model developed by clinical geneticists in Edinburgh offers a useful tool for physicians making decisions relating to genetic testing, although its clinical application in patients with colorectal cancer for the identification of [more]
Selected press reports compiled by the ESO Download full article
Selected press reports complied by the ESO Cancer Media Centre Download full article
Use of at least two standard aspirin weekly, for 10 years or more, reduces colon cancer risk in women. Subject to certain caveats, aspirin should be considered for colon cancer prophylaxis. Download full article
A panel of experts is predicting that colorectal cancer patients will soon feel the benefits of the sort of individualised therapies that are beginning to be used in breast cancer. More effort is needed to [more]
Selected press reports compiled by the ESO Cancer Media Centre Download full article
Hopes for a drug that could inhibit colorectal cancer took a knock last year due to revelations of serious side-effects. But a combination therapy may now offer a way forward. Download full article